Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Etanercept on Endothelial Function and Carotid Intima-media Thickness (IMT) in Patients With Active AS

NCT00910273 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00910273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00910273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Etanercept on Endothelial Function and Carotid Intima-media Thickness (IMT) in Patients With Active AS
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2009
Completion date
October 31, 2011
Enrollment
34 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis